February 29, 2024
A rare condition known as IgG4-related disease, or IgG4-RD, can burden patients with a complex web of symptoms, trouble obtaining a diagnosis and a seemingly endless series of treatment barriers. Many patients experience significant emotional and financial impacts too.
November 13, 2023
Schizophrenia is a serious mental illness that affects roughly 2 million Americans.
June 12, 2023
In the United States, health insurance is meant to reduce patients’ financial risks if they require expensive medical services. It often fails to do so. The problem is particularly acute for patients who need expensive prescription medications.
June 1, 2023
Calculating the value of a good or service is a complex process. Value, after all, reflects people’s personal preferences and context that is difficult to quantify. Even under the best of circumstances, it is hard to capture factors that are inherently subjective.
February 9, 2023
Nearly half of Americans report symptoms of anxiety or depressive disorder.
January 11, 2023
RSV, or respiratory syncytial virus, is a common, highly contagious seasonal virus that affects 97% of children by the age of 2.
December 19, 2022
At some point in their lives, most patients encounter insurance delays or denials for a prescription medication. But do certain groups of patients encounter these barriers more often than others? And at what cost?
October 25, 2022
Patients with rare diseases often struggle to get a timely diagnosis and proper treatment.
October 24, 2022
On 13 July 2022, the Alliance for Patient Access’ Rare Diseases Working Group hosted a virtual discussion on primary hyperoxaluria type 1.
October 13, 2022
Tezepelumab is a novel severe asthma treatment that was approved for clinician administration in late 2021. After a few months on the market, however, several Medicare Administrative Contractors made the unprecedented decision to place tezepelumab, a biologic approved for physician administration, on the Self-Administered Drug list.
